Molecular biomarkers of chemoradiation response in bladder preservation therapy.

被引：0
|
作者：
Miyamoto, David T. [1 ,2 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
来源：
CLINICAL CANCER RESEARCH | 2020年 / 26卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA25
引用
收藏
页码：23 / 24
页数：2
相关论文
共 50 条
  • [1] Molecular biomarkers in bladder preservation therapy for muscle-invasive bladder cancer
    Miyamoto, David T.
    Mouw, Kent W.
    Feng, Felix Y.
    Shipley, William U.
    Efstathiou, Jason A.
    [J]. LANCET ONCOLOGY, 2018, 19 (12): : E683 - E695
  • [2] Bladder preservation with trimodality therapy. Is it really necessary?
    Angulo, J.
    [J]. ACTAS UROLOGICAS ESPANOLAS, 2010, 34 (09): : 745 - 748
  • [3] Molecular biomarkers as predictors of response to neoadjuvant chemoradiation therapy in rectal cancer
    Milgrom, Sarah A.
    Garcia-Aguilar, Julio
    [J]. SEMINARS IN COLON AND RECTAL SURGERY, 2013, 24 (03) : 119 - 124
  • [4] Biomarkers for Predicting Clinical Outcomes of Chemoradiation-Based Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer
    Koga, Fumitaka
    Takemura, Kosuke
    Fukushima, Hiroshi
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (09)
  • [5] Predictive biomarkers of response to neoadjuvant therapy.
    Mouw, Kent W.
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (15) : 22 - 23
  • [6] Organ preservation by chemoradiation for bladder cancer
    Durdux, C.
    Fabiano, E.
    Mejean, A.
    [J]. CANCER RADIOTHERAPIE, 2019, 23 (6-7): : 732 - 736
  • [7] INTRATUMORAL HETEROGENEITY IN RECTAL CANCER MAY LIMIT THE ABIITY FOR THE MOLECULAR PREDICTION OF RESPONSE TO NEOADJUVATN CHEMORADIATION THERAPY.
    Perez, R.
    Habr-Gama, A.
    Bettoni, F.
    Masotti, C.
    Correa, B.
    Galante, P.
    Gama-Rodrigues, J.
    Fernandez, L.
    Sao Juliao, G.
    Camargo, A.
    [J]. DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : E59 - E59
  • [8] Outcomes of radical cystectomy in potential candidates for bladder-preservation therapy.
    Pietzak, Eugene J.
    Smith, Zachary L.
    Malkowicz, S. Bruce
    Guzzo, Thomas J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [9] Advancing bladder preservation: Biomarkers, decision-making, and therapy
    McConkey, David
    Best, Carolyn J. M.
    Gumminger, Julia A.
    Olumi, Aria F.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (04) : 199 - 200
  • [10] RECTAL CANCER BIOMARKERS AS PREDICTORS OF RESPONSE TO NEOADJUVANT THERAPY.
    Douglas, J. K.
    Hothem, Z. A.
    Wasvary, H.
    Cousineau, C.
    Peeples, C.
    Thibodeau, B.
    Li, W.
    Kawak, S.
    [J]. DISEASES OF THE COLON & RECTUM, 2018, 61 (05) : E156 - E156
12345